The FDA has approved Itvisma for the treatment of children two years and older, teens and adults living with spinal muscular ...
Novartis wins FDA approval for Itvisma, a one-time gene therapy offering broader SMA treatment with sustained motor function ...
US FDA approves Novartis’ Itvisma, the only gene replacement therapy for children two years and older, teens, and adults with SMA: Basel Wednesday, November 26, 2025, 09:00 Hrs ...
ITVISMA is a prescription gene therapy used to treat adults and children 2 years of age and older with spinal muscular atrophy (SMA). ITVISMA is given as a one-time intrathecal injection. What is the ...
Novartis secured approval for its drug to treat certain patients diagnosed with spinal muscular atrophy from the Food and Drug Administration.
Ad hoc announcement pursuant to Art. 53 LR Itvisma (onasemnogene abeparvovec-brve) demonstrated improved motor function and stabilization in patients regardless of SMA treatment history in Phase III ...
One of the most important functions of interneurons in the knee-jerk reflex is to mediate reciprocal inhibition. This process ensures that the contraction of the quadriceps muscle is accompanied by ...
New research reveals that neurons release a little-understood extracellular kinase called VLK to strengthen synaptic ...
“Those big teams of researchers are what you need to solve the world’s problems today,” she says. “The big collaborations are ...
Strain: An injury to a muscle or tendon caused by overstretching or tearing. Strains are graded based on severity: Grade I: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback